Zhou Ziyuan, Pan Xiaxia, Li Lanjuan
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Cell Dev Biol. 2022 Nov 22;10:1070208. doi: 10.3389/fcell.2022.1070208. eCollection 2022.
Hepatic macrophages have been recognized as primary sensors and responders in liver inflammation. By processing host or exogenous biochemical signals, including microbial components and metabolites, through the gut-liver axis, hepatic macrophages can both trigger or regulate inflammatory responses. Crosstalk between hepatic macrophages and gut microbiota is an important component of liver inflammation and related liver diseases, such as acute liver injury (ALI), alcoholic liver disease (ALD), and nonalcoholic fatty liver disease (NAFLD). This review summarizes recent advances in knowledge related to the crosstalk between hepatic macrophages and gut microbiota, including the therapeutic potential of targeting hepatic macrophages as a component of gut microecology in inflammation-associated liver diseases.
肝巨噬细胞已被公认为肝脏炎症中的主要传感器和反应细胞。通过肠道-肝脏轴处理宿主或外源性生化信号,包括微生物成分和代谢产物,肝巨噬细胞既能触发也能调节炎症反应。肝巨噬细胞与肠道微生物群之间的相互作用是肝脏炎症及相关肝脏疾病(如急性肝损伤、酒精性肝病和非酒精性脂肪性肝病)的重要组成部分。本文综述了肝巨噬细胞与肠道微生物群相互作用的最新研究进展,包括将靶向肝巨噬细胞作为肠道微生态的一个组成部分用于炎症相关肝病的治疗潜力。